Tel Aviv, Israel-based Memic changed the name of its Hominis system for robotic-assisted transvaginal hysterectomy to the Anovo surgical system. Last week, the company announced that HCA Florida Kendall Hospital and The Women’s Hospital at Jackson Memorial successfully completed the first U.S. patient procedures using Anovo, the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, elbow, and wrist joints that provide high dexterity and unprecedented articulation.
The Anovo system has indication for use in robotic-assisted transvaginal benign surgical procedures including benign hysterectomy, salpingectomy, oophorectomy, adnexectomy, and ovarian cyst removal. Multiple instruments can be introduced to the body through a single portal and the robotic arm articulation offers optimal access and working angles, Momentis said.
According to a news release, the company unveiled its rebranding effort in a special on-site event called “Project M” on Friday, July 1, 2022, at the Society of Robotic and Digital Surgery (SRS) 2022 Annual Meeting in Florida.
“We are pleased to announce our new identity as Momentis Surgical. As an innovative and visionary technology company, we want to ensure that our brand aligns with our vision and core values and reflects our expanded corporate mission to transform the field of robotic surgery in a range of indications using next-generation surgical robots that provide a human touch, mirroring the movements of the human body to enable surgeons to perform procedures previously unimaginable,” Momentis CEO Dvir Cohen said in the release. “We believe the name Momentis captures not only where we find ourselves as a company today, but it reflects our inspiration for future growth as an organization.”
